In conclusion, this study revealed that fucoidan inhibited alcohol-induced steatosis and disorders of bile acid metabolism via the AMPK/SIRT1 pathway and the gut microbiota–bile acid–liver axis. This evidence concerns the gene PRKAA1 and steatosis.